Colgate-Palmolive Company (NYSE:CL) Shares Acquired by J.W. Cole Advisors Inc.

J.W. Cole Advisors Inc. increased its stake in Colgate-Palmolive Company (NYSE:CL - Free Report) by 65.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 25,402 shares of the company's stock after acquiring an additional 10,005 shares during the period. J.W. Cole Advisors Inc.'s holdings in Colgate-Palmolive were worth $2,380,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the stock. BKM Wealth Management LLC grew its holdings in shares of Colgate-Palmolive by 22.9% during the first quarter. BKM Wealth Management LLC now owns 10,191 shares of the company's stock worth $955,000 after purchasing an additional 1,900 shares during the last quarter. Twin Capital Management Inc. grew its holdings in shares of Colgate-Palmolive by 466.0% during the first quarter. Twin Capital Management Inc. now owns 18,112 shares of the company's stock worth $1,697,000 after purchasing an additional 14,912 shares during the last quarter. OneAscent Family Office LLC grew its holdings in shares of Colgate-Palmolive by 105.3% during the first quarter. OneAscent Family Office LLC now owns 6,106 shares of the company's stock worth $572,000 after purchasing an additional 3,132 shares during the last quarter. AustralianSuper Pty Ltd grew its holdings in shares of Colgate-Palmolive by 18.1% during the first quarter. AustralianSuper Pty Ltd now owns 1,344,469 shares of the company's stock worth $125,977,000 after purchasing an additional 205,814 shares during the last quarter. Finally, South Dakota Investment Council grew its holdings in shares of Colgate-Palmolive by 24.4% during the first quarter. South Dakota Investment Council now owns 25,721 shares of the company's stock worth $2,410,000 after purchasing an additional 5,050 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several equities analysts have issued reports on CL shares. Wall Street Zen lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. JPMorgan Chase & Co. increased their target price on shares of Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a research note on Monday, April 28th. UBS Group decreased their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating for the company in a research note on Thursday, July 17th. Barclays increased their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research note on Tuesday, July 15th. Finally, Wells Fargo & Company increased their target price on shares of Colgate-Palmolive from $83.00 to $88.00 and gave the stock an "underweight" rating in a research note on Wednesday, April 2nd. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $100.64.

Colgate-Palmolive Stock Down 0.2%

CL stock opened at $86.67 on Tuesday. The stock has a market capitalization of $70.24 billion, a P/E ratio of 24.48, a PEG ratio of 4.59 and a beta of 0.37. The company has a debt-to-equity ratio of 8.96, a quick ratio of 0.54 and a current ratio of 0.85. Colgate-Palmolive Company has a one year low of $85.32 and a one year high of $109.30. The company has a 50 day moving average price of $90.34 and a two-hundred day moving average price of $90.38.

Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.86 by $0.05. The firm had revenue of $4.91 billion during the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a net margin of 14.52% and a return on equity of 461.04%. Colgate-Palmolive's revenue for the quarter was down 3.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.86 EPS. As a group, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 15th. Stockholders of record on Friday, July 18th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 annualized dividend and a dividend yield of 2.40%. Colgate-Palmolive's dividend payout ratio is presently 58.76%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.